Hoyoung M. Maeng, M.D.

Hoyoung M. Maeng, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Vaccine Branch


Dr. Maeng’s research interests focus on therapeutic vaccines in cancer as well as novel strategies to treat precancerous lesions in patients with chronic viral infection. She believes that the essence of the Center for Cancer Research, NCI is the "bench-to-bedside" exemplfied by the vaccine that was created here at NCI to treat patients in the NIH Clinical Center. She leads the clinical trials team in the Vaccine Branch as a clinical PI.

Areas of Expertise

1) therapeutic vaccine 2) cancer immunotherapy 3) clinical trial

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.


Selected Key Publications

Cancer vaccines: translation from mice to human clinical trials

Hoyoung Maeng - Center for Cancer Research Masaki Terabe - Center for Cancer Research Jay A Berzofsky
Current Opnion in Immunology. 51: 111-122, 2018. [ Journal Article ]

Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein

Berkova Z, Wang S, Wise JF, Maeng H, Ji Y, Samaniego F.
J. Natl. Cancer Inst. 101(6): 399-411, 2009. [ Journal Article ]

K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis

Wang S, Wang S, Maeng H, Young DP, Prakash O, Fayad LE, Younes A, Samaniego F.
Blood. 109(5): 2174-82, 2007. [ Journal Article ]


Special Volunteer (NCATS)
Haksong Jin, PharmD
Research Nurse
Santhana Webb, R.N., O.C.N.
Data Manager (Contr.)
Giselle Martinez
Special Volunteer
Grace Jin